A study published in JAMA Internal Medicine suggests that Pfizer’s Chantix, a smoking cessation drug, is safe for your heart — a big relief for smokers, doctors, and treatment facilities alike.

8,000 smokers were randomly assigned Chantix and three other similar cessation medicines for 12 weeks, while an extended study followed 2,400 participants for 12 months. According to WHNT News, ”there were five heart-related deaths and 22 nonfatal heart attacks and strokes, pretty evenly distributed among the four groups”, both during and after the treatment.

The findings conclude that Chantix, which blocks the effects of nicotine on the brain, is as safe for the heart as nicotine patches and placebo pills. By the end of the study, 34% of those taking Chantix had quit smoking, the most successful of the four treatment options tested.

Researchers noted that many of the participants did have high blood pressure and other risks for heart problems prior to the study. The findings are great news to doctors and treatment facilities for smoking addicts. “We now know it’s a lot safer to use these drugs to help people quit smoking than to continue smoking”, says Dr. Nancy Rigotti, from the Massachusetts General Hospital Tobacco Research and Treatment Center.

Buy Chantix easily, online at KwikMed.